Home > Healthcare & Medical Devices > Blepharoplasty Market
Blepharoplasty Market size is poised to expand significantly between 2023 and 2032, attributed to the rising awareness about the benefits of eyelid surgery, including vision improvement and dark circles removal, among others.
Blepharoplasty is a type of plastic surgery that rectifies drooping eyelids by removing skin, fat, and muscle to enhance the function and look of the eyelids. This operation is classified based on need into three types viz., double, lower, and upper eyelid blepharoplasty.
The growing acceptance of blepharoplasty as a popular cosmetic surgery among men and women worldwide, particularly in the U.S., will boost blepharoplasty market growth during the estimated timeline. According to a survey conducted by the American Society of Plastic Surgeons, approximately 30% of cosmetic plastic surgery clinics have witnessed over two-fold rise in demand for their services since the COVID-19 outbreak began.
However, potential risks associated with eyelid surgery, such as dry or irritated eyes, infection and bleeding, skin discoloration, and visible scars, may limit blepharoplasty acceptance in the coming years.
Furthermore, the rapidly rising inflation rate may limit product adoption. For example, the United Kingdom is anticipated to hit an 18% inflation rate in January 2023. This will have a devastating impact on several aspects of everyday life, including physical appearance. Cosmetic surgery has become a luxury not everyone can afford. Therefore, consumer preferences may alter dramatically to keep up with inflation and stay under budget, which, in consequence, may hamper market performance.
As per procedure, the blepharoplasty market by the upper eyelid blepharoplasty segment is anticipated to record considerable revenue from 2023 to 2032. Apart from cosmetic reasons, upper eyelid blepharoplasty surgery is performed on older persons to relieve visual impairment caused by drooping skin. The expanding elderly population base and the growing popularity of upper eyelid procedures, particularly in Asian nations, is the primary driver expected to foster segment gains through 2032.
In terms of end-user, ambulatory surgery centers are expected to hold a sizeable portion of the blepharoplasty market during 2023-2032. The growing adoption of minimally invasive methods and the increasing availability of modern technology and skilled specialists across these facilities are driving segment outlook. Moreover, low costs, increased safety, high convenience, and better accessibility of outpatient surgery centers as compared to hospital settings will also accelerate segment expansion during the next ten years.
The Europe blepharoplasty industry is forecast to grow substantially through 2032 due to the expanding number of baby boomers and the emergence of eyelid surgery as one of the most popular treatments across the United Kingdom.
According to a study conducted by the British Association of Aesthetic Plastic Surgeons, requests for virtual consultations for surgical procedures jumped by 70% during the lockdown in preparation for in-person treatment following the lockdown. In addition, the growing number of plastic surgeons in the UK will contribute to the regional share between 2023 and 2032.
The competitive landscape of the global blepharoplasty market includes prominent companies such as Bomtech Electronics Co., Luminera Derm Ltd., ThermiGen LLC, Levadent Ltd., GTG Wellness, IOPtima, Advance Medical Systems Inc., and Grand Aespio inc., among others.